1-5 of 5
Sandra B. Horowitz, PharmD
Close
Sort by
Journal Articles

High Response Rate of Romidepsin in Combination with ICE (Ifosfamide, Carboplatin and Etoposide) in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma: Updates of Phase I Trial

Dai Chihara, MD PhD, Yasuhiro Oki, MD, Jason R Westin, MD, Loretta Nastoupil, MD, Luis E. Fayad, MD, Felipe Samaniego, MD, Emily Wesson, APN, Charnelle Ruben, BS, Sandra B. Horowitz, PharmD, Lei Feng, MS, Naveen Garg, Sairah Ahmed, MD, Issa F. Khouri, Chitra M. Hosing, MD, Jorge E. Romaguera, MD, Nathan Fowler, MD, Michelle A. Fanale, MD
Journal: Blood
Blood (2015) 126 (23): 3987.
https://doi.org/10.1182/blood.V126.23.3987.3987
Published: 2015
Journal Articles

Gene Expression Profiling for Molecular Features of Response in a Phase I Trial of Alisertib Plus Romidepsin for Relapsed/Refractory Aggressive B- and T-Cell Lymphomas

Michelle A. Fanale, MD, Zhiqiang Wang, PhD, Wencai Ma, PhD, Yasuhiro Oki, MD, Fredrick B. Hagemeister, MD, Luis E. Fayad, MD, Nathan Fowler, MD, Jorge E. Romaguera, MD, Nina Shah, MD, Hubert H Chuang, MD PhD, Feng Lei, MS, Sandra B. Horowitz, PharmD, Dai Chihara, MD PhD, Emily Wesson, APN, Toni Y Hutto, BS, Charnelle Ruben, BS, Felipe Samaniego, MD, Tariq Muzzafar, MD, Richard Piekarz, PhD MD, R Eric Davis, MD
Journal: Blood
Blood (2015) 126 (23): 2705.
https://doi.org/10.1182/blood.V126.23.2705.2705
Published: 2015
Journal Articles

A Phase I Trial of Alisertib Plus Romidepsin for Relapsed/Refractory Aggressive B- and T-Cell Lymphomas

Michelle A. Fanale, MD, Fredrick B. Hagemeister, MD, Luis Fayad, MD, Yasuhiro Oki, MD, Nathan Fowler, MD, Jorge Romaguera, MD, Nina Shah, Hubert Chuang, MD, Lei Feng, MS, Sandra B Horowitz, PharmD, Emily Wesson, APN, Toni Y Hutto, BS, Tariq Muzzafar, MD, Felipe Samaniego, MD, R Eric Davis, MD
Journal: Blood
Blood (2014) 124 (21): 1744.
https://doi.org/10.1182/blood.V124.21.1744.1744
Published: 2014
Journal Articles

Phase I Study of Romidepsin in Combination with ICE (Ifosfamide, Carboplatin and Etoposide) in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma

Dai Chihara, MD PhD, Yasuhiro Oki, MD, Luis Fayad, MD, Emily Wesson, APN, Charnelle Ruben, Sandra B Horowitz, PharmD, Joseph Woolery, PharmD, Lei Feng, MS, Naveen Garg, Sairah Ahmed, MD, Issa F. Khouri, MD, Michelle A. Fanale, MD
Journal: Blood
Blood (2014) 124 (21): 1748.
https://doi.org/10.1182/blood.V124.21.1748.1748
Published: 2014
Journal Articles

Positive Maternal-Fetal Outcomes with Treatment of Lymphoma During Pregnancy: UT MD Anderson Cancer Center Prospective Experience

Michelle A. Fanale, MD, Chao-Ming Lai, APN, Sue A Rimes, RN, Mildred M Ramirez, MD, Fredrick B Hagemeister, MD, Nathan H Fowler, MD, Anas Younes, MD, Luis E Fayad, MD, Maria Alma Rodriguez, MD, Francesco Turturro, MD, Felipe Samaniego, MD, MPH, Jorge E Romaguera, MD, Victor A Levin, MD, Sandra B Horowitz, PharmD, Joseph E Woolery, PharmD, Andrea Milbourne, MD
Journal: Blood
Blood (2012) 120 (21): 3670.
https://doi.org/10.1182/blood.V120.21.3670.3670
Published: 2012